Monomorphic ventricular tachycardia: A late complication of percutaneous alcohol septal ablation for hypertrophic cardiomyopathy

American Journal of the Medical Sciences

Volumn 328, Issue 3, 2004, Pages 185-188

  McGregor, Jon Brant ^a   Rahman, Atiar ^a   Rosanio, Salvatore ^a   Ware, David ^a   Birnbaum, Yochai ^a   Saeed, Mohammad ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b 5106 John Sealy Annex ^*  (United States)

Author keywords

Alcohol septal ablation; Hypertrophic cardiomyopathy; Ventricular tachycardia

Indexed keywords

ALCOHOL;

ADULT; ARTICLE; CASE REPORT; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; ENDOSCOPIC SCLEROTHERAPY; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IATROGENIC DISEASE; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; MONOMORPHIC VENTRICULAR TACHYCARDIA; PERCUTANEOUS ALCOHOL SEPTAL ABLATION; REENTRY ARRHYTHMIA; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 4644237499     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200409000-00011     Document Type: Article

References (10)

1. Sherrid MV, Pearle G, Gunsburg DZ. Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Circulation 1998;97:41-7.
2. Morrow AG, Reitz BA, Epstein SE, et al. Operative treatment in hypertrophic subaortic stenosis: techniques, and the results of pre and postoperative assessments in 83 patients. Circulation 1975;52:88-102.
3. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-4.
4. Faber L, Meissner A, Ziemssen P, et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients. Heart 2000;83:326-31.
5. Gietzen FH, Leuner CJ, Raute-Kreinsen U, et al. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH): catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 1999;20:1342-54.
6. Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997;95:2075-81.
7. Lakkis NM, Nagueh SF, Kleiman NS, et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998;98:1750-5.
8. Maron BJ. Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet 2000;355:425-6.
9. Seggewiss H, Faber L, Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg 1999;47:94-100.
10. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-73.